Dose Finding Study To Assess Safety, Pk And Efficacy Of Fimepinostat (Cudc‐907) With Venetoclax Or Rituximab Plus Bendamustine In Patients With Relapsed/Refractory Lymphoma
Younes, A.; Batlevi, C.L.; Cohen, J.B.; Kelly, K.; Landsburg, D.J.; Patel, K.; Phillips, T.; Smith, S.; Westin, J.; Ma, A.W.; Grayson, D.; Barta, S. (Wiley Periodicals, Inc., 2019-06)
(159.2KB)